FDA approves new drug for multiple sclerosis

Author(s):

On March 26, the FDA approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

Read more at FDA.gov.

LEAVE A REPLY

Please enter your comment!
Please enter your name here